30 results
8-K
EX-99.1
MKULQ
Molekule Group, Inc.
16 Aug 23
Molekule Reports Second Quarter 2023 Financial Results
7:15am
, healthcare and B2B. Through our commitment to research and innovation, we have developed cutting-edge technologies and rigorous quality standards
424B3
gospvvfl9gc3k0f
20 Dec 22
Prospectus supplement
7:34pm
S-4
sh5qay1ea1f3 02ru
19 Dec 22
Registration of securities issued in business combination transactions
11:54am
DRS
36v64txedne bj6
9 Nov 22
Draft registration statement
12:00am
425
zbh96ly bh7dko
4 Oct 22
Business combination disclosure
6:14am
425
nukrn
4 Oct 22
Business combination disclosure
6:11am
425
EX-2.1
d7je38imi27x6b
4 Oct 22
Business combination disclosure
6:10am
425
EX-99.1
t32ccqjtxalwv3 13j
4 Oct 22
Business combination disclosure
6:10am
425
EX-3.2
qfa zkjonf
4 Oct 22
Business combination disclosure
6:10am
425
EX-10.3
rg27vo
4 Oct 22
Business combination disclosure
6:10am
8-K
EX-10.3
xuz9p4x5 q3s4vgjo2xv
4 Oct 22
Entry into a Material Definitive Agreement
6:08am
8-K
EX-99.1
0xwtzn6u99pittm
4 Oct 22
Entry into a Material Definitive Agreement
6:08am
8-K
EX-2.1
77o047m
4 Oct 22
Entry into a Material Definitive Agreement
6:08am
8-K
EX-3.2
l1i1s5
4 Oct 22
Entry into a Material Definitive Agreement
6:08am